series-a
Stage
2
Investors
About
Orvida Pharma is a clinical-stage biotechnology company developing disease-modifying oral and topical TRPV3 inhibitors to treat rare, severe genetic skin diseases, including Olmsted syndrome.
Explore Orvida Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.